Class IV Laser Therapy for Peripheral Neuropathy: A Drug-Free Path to Relief

Peripheral neuropathy affects an estimated 20 million Americans, with diabetic peripheral neuropathy (DPN) representing the single largest subgroup. It occurs when the peripheral nerves - those that carry signals between the brain, spinal cord, and the rest of the body - are damaged. In the foot and ankle, this produces the classic symptoms most patients describe: burning, tingling, "pins and needles," electric shocks, and eventually a loss of sensation that makes every step a fall risk.

At Vertex Podiatry, we treat neuropathy with the Remy Class IV Laser - a 510(k) FDA-cleared device that works at the cellular level to promote nerve repair, improve circulation, and reduce pain - without adding another pill to your prescription list.

Why Conventional Treatments Often Fall Short

The standard pharmacologic management of peripheral neuropathy includes medications like gabapentin (Neurontin), pregabalin (Lyrica), duloxetine (Cymbalta), and tricyclic antidepressants. These drugs share a common mechanism: they dampen nerve signal transmission. In other words, they mask the pain rather than addressing the underlying nerve damage.

Side effects are significant - sedation, weight gain, cognitive fog, and dependency. More importantly, none of these medications promote nerve regeneration. Patients often find themselves on escalating doses, experiencing diminishing returns, while the underlying nerve damage continues to progress.

How Class IV Laser Therapy Works for Neuropathy

Laser therapy takes a fundamentally different approach: rather than suppressing pain signals, it works with the nerve's own biology to promote healing.

ATP Production and Cellular Energy

Near-infrared laser light is absorbed by the mitochondria inside nerve cells. This triggers a dramatic increase in ATP (adenosine triphosphate) - the energy currency of every cell. When nerve cells have more energy available, they can repair damaged myelin sheaths, regenerate axons, and restore normal signal conduction more effectively.

Improved Microcirculation

One of the hallmarks of diabetic neuropathy is impaired microvascular blood flow - the tiny capillaries that supply oxygen and nutrients to peripheral nerves become diseased. Class IV laser therapy has been shown to stimulate capillary formation (angiogenesis) and increase blood flow to hypoxic tissues. Better circulation means the nerves receive more of what they need to heal.

Reduction of Inflammatory Mediators

Chronic low-grade inflammation is a driver of neuropathic pain. Laser therapy modulates the production of pro-inflammatory cytokines and activates the body's lymphatic drainage system, reducing the inflammatory burden on already-stressed nerve tissue.

Beta-Endorphin Release

Laser energy stimulates the release of beta-endorphins - the body's endogenous opioids. These naturally block pain signal transmission along damaged nerve pathways, providing relief that many patients describe as "the first time my feet haven't hurt in years."

What to Expect from Treatment

A typical laser course for peripheral neuropathy involves 6-10 sessions over 3-6 weeks. Sessions are painless - the laser wand is moved methodically over the affected area as you feel a gentle, soothing warmth. Each session lasts approximately 10-20 minutes. There is no downtime.

Most patients begin to notice improvement in pain, burning, and tingling within the first 3-4 sessions. Improvements in sensation (particularly in patients with early-to-moderate neuropathy) may take longer, as nerve regeneration is a slow biological process. We track your response and adjust the treatment protocol accordingly.

Who Benefits Most from Laser Therapy for Neuropathy?

• Patients with diabetic peripheral neuropathy - the most common and most progressive form
• Patients who have not responded adequately to gabapentin or pregabalin
• Patients seeking to reduce their medication burden - laser can be used alongside existing treatments
• Patients with chemotherapy-induced peripheral neuropathy (CIPN)
• Patients with idiopathic neuropathy - where no systemic cause has been identified

Why Early Treatment Matters

Peripheral neuropathy tends to be progressive, particularly in the setting of diabetes. Once sensation is completely lost in the feet, the risk of undetected wounds, ulceration, and infection rises dramatically. Diabetic foot complications are the leading cause of non-traumatic lower limb amputation in the United States. Early intervention - before sensation is completely gone - gives laser therapy its best opportunity to slow progression and preserve function.

Schedule Your Evaluation

If you are living with burning, tingling, numbness, or pain in your feet - or if your current neuropathy medications are not providing adequate relief - we encourage you to explore laser therapy as an option. Schedule a consultation with Dr. Guy Golan, DPM in Grandview Heights, or call (614) 328-5561.